Small Molecules

20 Jul 2007 HMP approves labelling update of Acomplia(R) in Europe and confirms the positive benefit-risk profile of the product except in patients suffering from ongoing major depression
19 Jul 2007 Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
19 Jul 2007 U.S. FDA and European EMEA Accept Registration Applications for Ceftobiprole, a Novel Anti-MRSA Broad-Spectrum Cephalosporin
19 Jul 2007 Mpex Pharmaceuticals Initiates Multi-dose Clinical Trial in the U.S. with MP-376 in Patients with Cystic Fibrosis
19 Jul 2007 New Drug Application for Investigational HIV Treatment TMC125 Submitted to U.S. Food and Drug Administration
19 Jul 2007 Merck Transfers Abbott Rights for Niaspan Outside the U.S.
18 Jul 2007 Cortex to Resume Clinical Trial with AMPAKINE® CX717 in Alzheimer-PET Scan Study after FDA Approves Protocol with Higher Doses of Drug
18 Jul 2007 Metabasis Therapeutics Announces CS-917 Phase 2b Clinical Trial Results and Reports on Status of Pradefovir
18 Jul 2007 RSV Drug Starts Phase Ia Clinical Trials
18 Jul 2007 Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
18 Jul 2007 DURECT Reports Positive Results from POSIDUR(TM) Phase IIb Hernia Trial, Triggering $8 million Milestone Payment from Nycomed
18 Jul 2007 FDA Approves Extina(R) for the Treatment of Seborrheic Dermatitis
18 Jul 2007 Sirtris Pharmaceuticals Presents Results of Studies of SIRT1 Activators at 6th Annual Metabolic Diseases Drug Discovery and Development World Summit
18 Jul 2007 Theratechnologies Regains Japanese Rights for TH9507
18 Jul 2007 ABILIFY(R) (aripiprazole) Supplemental New Drug Application Receives Priority Review by U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
18 Jul 2007 Salix Pharmaceuticals Announces Submission Of Balsalazide Tablet New Drug Application
18 Jul 2007 PPD Completes First-in-Human Trial for Novel Statin
17 Jul 2007 Amira Pharmaceuticals Starts First Clinical Trial of Lead Compound With Potential in Asthma and Cardiovascular Disease
17 Jul 2007 Roche And BioCryst Advance BCX-4208/R3421 Into Phase II Psoriasis Trial
17 Jul 2007 NicOx receives Euro 5 million milestone from Merck & Co., Inc.
17 Jul 2007 Prometic and Laboratorios Dermatologicos Darier S.A. enter into agreement for PBI-1308 with respect to dermatological disorders
17 Jul 2007 ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate
17 Jul 2007 Millennium Initiates Phase III Trial to Determine the Optimal VELCADE(R) (Bortezomib) for Injection Based Therapy in Newly Diagnosed Multiple Myeloma Patients
17 Jul 2007 Hollis-Eden Pharmaceuticals Reports Initial Results in Phase I Clinical Trial of HE3286 as New Type II Diabetes Treatment
17 Jul 2007 Can-Fite Reports Results of a Phase IIb Clinical Study in Rheumatoid Arthritis with CF101, an A3 Adenosine Receptor Agonist. The Results Support Further Clinical Development of CF101

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top